Actively Recruiting
Understanding of Psychotic Disorders in Children With 22q11.2DS
Led by Hôpital le Vinatier · Updated on 2025-07-30
80
Participants Needed
1
Research Sites
306 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome
CONDITIONS
Official Title
Understanding of Psychotic Disorders in Children With 22q11.2DS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of 22q11.2 deletion syndrome or no developmental disease
- Aged from 4 to 13 years old
- French language
You will not qualify if you...
- Diagnosis of intellectual deficiency according to DSM 5 criteria
- Drug prescribed for somatic condition that could influence cerebral functioning
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Vinatier
Lyon, Auvergne-Rhône-Alpes, France, 69678
Actively Recruiting
Research Team
C
Caroline DEMILY, MD PH
CONTACT
V
Véronique VIAL
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here